In June, Sanofi Aventis withdrew an application for a proposed weight-loss drug, rimonabant (Acomplia), that may provoke suicidal thoughts.

• 今年6月，生技公司赛诺菲安万特撤回对减肥药rimonabant（产品名Acomplia）的申请，因为该药物可能会引发自杀的念头；